Group of Nations SUMMITSSolutions Through Inclusivityby Group of Nations

Publisher of the first-ever G7 Summit publication, Denver 1997

See where your company fits

A question for your company

Which analysis on this page could your company add a solution to?

Share your answer over a virtual coffee & a chat →
An Official Publication of America250. Declaring Freedom: the founders and the birth of a nation. Order your copy at shop.groupofnations.com An Official Publication of America250. Icons of the Open Road: Route 66 and landmarks from all 50 states. Order your copy at shop.groupofnations.com An Official Publication of America250. Gridiron Evolution: America’s game, from Canton to the world. Order your copy at shop.groupofnations.com An Official Publication of America250. To the Moon and Beyond: America’s space legacy. Order your copy at shop.groupofnations.com
Official America250 Commemorative Posters in Full Color, Old Style and Black & White, 18 x 24 in. Order at shop.groupofnations.com
With congratulations on America’s 250th Anniversary, from JMI-IBNF, PEACE and the Global Alliance CouncilAdvertisement
Group of Nations supports Birmingham Care Group as its charity of choice. Donate now at birminghamcaregroup.org Sea Menace, a feature documentary on sargassum. One fisherman. One bloom. One ocean. One world connected. Supported by Groupofnations.com. Donate now at gofundme.com/f/support-sea-menace

Analysis · G7 · Cancer

G7 health ministers set out a cancer roadmap built on data sharing and earlier diagnosis

A roadmap published by France’s G7 presidency on October 19 turns the leaders’ June cancer pledge into two work streams: pediatric cancer data and cancers with poor prognosis.

October 21, 2026 · 3 min read

Institut Gustave Roussy cancer center in Villejuif, France
Institut Gustave Roussy, Villejuif, France. Photo: Chabe01, via Wikimedia Commons (CC BY-SA 4.0)

G7 health ministers have endorsed a roadmap to speed up delivery of the cancer commitments G7 leaders made in June. France’s G7 presidency published the text on October 19, 2026. It concentrates on two areas: cross-border access to data on cancers in children, adolescents and young adults, and cancers with poor prognosis, such as pancreatic and lung cancer.

For pharmaceutical, diagnostics, medical technology and health data companies, the roadmap shows where G7 governments intend to coordinate: registry interoperability, clinical trial cooperation, screening programs and the use of artificial intelligence in cancer care.

The case the ministers make

The roadmap says cancer causes nearly 10 million deaths a year worldwide and that new cases are expected to rise by 80% globally by 2050, driven by population aging and environmental and behavioral risk factors. It says lung cancer alone accounts for 12% of all cancers and 18% of cancer deaths worldwide, and that its incidence among women is rising by about 5% a year.

It builds on the G7 leaders’ call on the fight against cancer, published June 17, 2026. In that text, leaders committed to work on pediatric cancers, cancers with poor prognosis and access to care, and to significantly reduce lung cancer mortality within ten years.

Two pillars

The first pillar covers cancers in children, adolescents and young adults. Because many of these cancers are rare and highly varied, the roadmap says no single country can produce robust enough data on its own. Ministers say they intend to promote cooperation among existing data programs to network national registries, advance interoperability standards and support the integration of clinical, genomic and imaging data without requiring direct data transfers. The roadmap says this should follow applicable legal and regulatory frameworks and may draw on AI where appropriate.

The second pillar covers cancers with poor prognosis. The roadmap says that for these cancers, fewer than 25% of patients remain disease-free in the first year after treatment and five-year survival is below 30%. Ministers intend to support work toward a shared international definition and research agenda, set ambitious targets for screening and for the share of cancers diagnosed at stage I, as appropriate to national systems, and improve cooperation on clinical trials. The text also encourages evidence-based lung cancer screening programs for eligible populations and names Cancer Grand Challenges among the existing initiatives to build on, subject to available resources.

What it means for business

The roadmap is voluntary. Its commitments are conditioned throughout on national law, priorities, capacities and resources, and it does not announce new funding. It does signal the areas where public health systems in G7 countries plan to align: privacy-preserving data analysis, molecular characterization and biomarkers, earlier diagnosis, innovative clinical trial designs and access to new therapies.

The text also states that access to safe and effective antimicrobials, including antibiotics, remains essential to prevent and treat infections linked to many cancer treatments. It says an informal coordination group of national cancer institutes and research organizations intends to help align existing initiatives to support implementation.

Sources

Source: www.elysee.fr

Would you be against a virtual coffee & a chat? A cup of coffee framed by G7, G20, APEC and COP
Chris Atkins
Chris AtkinsPresident & Founder, Group of Nations

Would you be against a virtual coffee & a chat to see where your company fits?

Schedule your virtual coffee →

Click the image to order your virtual coffee & a chat. Pick a time that suits you; the video link comes with your calendar invitation.

More on G7

G7 page →

Read by ministers and government officials, delegations, embassies, CEOs and NGOs

We explain what was decided. Your company can show business leaders, delegations and NGOs how it gets done.

Clients that have shared their solutions

SamsungMastercardDeutsche BankPfizerBMW
Would you be against a virtual coffee & a chat to see where your company fits?
Front cover: The Advocacy Advantage by Chris Atkins

Free book · by Chris Atkins

The Advocacy Advantage

How the world’s top executives shape global stories

We’ll email you the book. Your address stays with Group of Nations.

Summit alerts

Know what is being published, before it is published.

A short note ahead of each summit — the edition in production, the deadline for inclusion, and what the presidency has put on the agenda. No more than one a month.

We publish for governments and Fortune 500 companies. Your address is used for these alerts only, and never sold.